This short piece serves to introduce our themed series entitled, "The Engineered 41
Gut: Use of Stem Cells and Tissue Engineering to Study Physiology and Disease." 42 Given the remarkable progress in our understanding of intestinal stem cells (ISCs)  43 over the last decade, it seems timely to review the topic of ISC in some depth. 44 Indeed, it has been approximately ten years since the first report of Lgr5 as an ISC 45 marker, and the creation of the Intestinal Stem Cell Consortium by the National 46
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The ISC field 47 and the Intestinal Stem Cell Consortium are moving into the next phase of discovery; 48 consequently it is reasonable to take stock of where we are and touch on the many 49 challenges that await us. 50
Theories of the origins of intestinal epithelial cells date back to the 1950's and 51
1960's, with the discovery of DNA and DNA labeling studies in rodents using 3 H-52 thymidine. Proliferation was found not to be evenly distributed throughout the 53 intestinal epithelium, but largely restricted to the lower three-fourths of the crypt, 54 with a general flow upwards. The initial concept was that if dedicated ISC exist, 55 they would reside at the base of the proliferative column, immediately above the 56 Paneth cells [3] . Detailed studies using autoradiography and electronic microscopy 57
by Cheng and Leblond enumerated the various progenitors, and these investigators 58 eventually came up with the "Unitarian Theory", suggesting that all four main 59 epithelial cell types (columnar, enteroendocrine, goblet and Paneth) are derived 60 from the same precursor [5] . Importantly, they identified undifferentiated (granule 61 free) potential progenitors located in the lower intestinal crypts (at cell positions +1 62 to +9) that they believed represented stem cells. Interestingly, some of these Crypt 63
Base Columnar (CBC) cells were located below Paneth cells at the +1 position. 64
Around the same time, Potten and Cairns were working on radiation studies in the 65 small intestine, studying the segregation of DNA, and found that radiation induced 66 apoptosis in a number of progenitors, but led to retention of the 3 H-thymidine DNA 67 label for more than 30 days by a subset of cells [11] . They went on to show that 68 these label-retaining cells are rare cells that reside between positions +2 to +10, 69 with a peak at +4 -+5; thus the concept of the label-retaining cell or + 4 cell was 70 developed [12] . As a result, for decades the general thinking was that the stem cell 71 compartment of the intestinal epithelium was achieved by a hierarchical age 72 structure, with rare, slowly dividing radioresistant cells at the top of the hierarchy. In the first phase of the ISCC ('Gen 1 ', 2009-2014) , there were 8 intestinal stem cell 97 research centers (Fig. 1A) , geographically well distributed, and coordinated by the 98 ISCC Coordinating Center at the City of Hope. A major goal of the consortium has 99 been to accelerate ISC research through collaborations and rapid exchange of 100 information, and to expand the tools available to the research community as a whole. 101
The ISCC initially focused on major questions in stem cell biology, including the role 102 of the CBC versus the +4 ISC, and the possible utility of other stem cell markers, with 103 a major focus on the mouse intestine. 
